Irritable bowel syndrome-constipation
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Comply with IBS C Roman IV diagnostic standard; 2) Aged between 18 and 70 years, gender is not limited; 3) Have not taken any medication related to the disease within at least one week before entering the study, and have not participated in any other ongoing study; 4) Colonoscopy was performed within 1 year (colon polyps, inflammatory bowel disease and other organic lesions were excluded); 5) Voluntary subject and informed consent signed by the participant; 6) Frequent residence in the location of treatment is conducive to treatment and follow-up.
Exclusion criteria
Exclusion criteria: 1) Alternate diarrhea and constipation with IBS; 2) Patients with previous heart, liver and kidney tumors and organic lesions or patients with mental illness; 3) Patients with previous gastrointestinal tumors and organic lesions, such as pancreatitis, intestinal polyps (not including polypectomy for more than half a month), intestinal diverticulum, history of colon or rectal cancer, inflammatory bowel history, intestinal tuberculosis, etc.; 4) Previous metabolic diseases affecting digestive tract motility, such as thyroid disease and diabetes mellitus; 5) People with previous gastrocardiac syndrome and lactase deficiency; 6) Allergic constitution or allergic to the components of the drug under study; 7) Pregnant or lactating women, and female patients with recent family planning; 8) Previous abdominal or pelvic surgery, such as cholecystectomy; 9) People who are taking other Chinese medicine for treatment; 10) According to the researchers' judgment, patients with conditions that reduce the possibility of enrolment or complicate enrolment, such as frequent changes in work environment, are prone to loss of follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritable bowel syndromes symptom severity score; | — |
Countries
China
Contacts
Wangjing Hospital China Academy of Chinese Medicine Sciences